Location: Fort Worth, TX
CIK: 0001536054 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 15, 2025
Total Value: $63.24M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DNLI | DENALI THERAPEUTICS INC | 4,160,732 | $56.57M | 89.5% | $33.82 | -43.3% | COM | 24823R105 |
| SANA | SANA BIOTECHNOLOGY INC | 2,790,937 | $4.689M | 7.4% | $21.17 | -86.8% | COM | 799566104 |
| EGHT | 8X8 INC NEW | 990,580 | $1.982M | 3.1% | $4.02 | -35.9% | COM | 282914100 |